Triflusal Triflusal Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA). Trade names include Disgren, Grendis, Aflen and Triflux. Triflusal is a selective platelet antiaggregant through; Triflusal is indicated for; In the 2008 guidelines for stroke management from the European Stroke Organization, triflusal was for the first time recommended as lone therapy, as an alternative to acetylsalicylic acid
Hippocrates (lunar crater) number of tiny craterlets, and is slightly wider at the southern edge with a ridge-like projection. The interior floor is level and almost featureless, with only a few tiny craterlets to mark the surface. This crater was named after Hippocrates, the ancient Greek physician. By convention these features are identified on lunar maps by placing the letter on the side of the crater midpoint that is closest to Hippocrates. Hippocrates (lunar crater) Hippocrates is a lunar impact crater on the far side of the Moon. It is located in the northern region of the lunar surface, to the north of